13F HOLDINGS REPORT
Tri Locum Partners LP
Quarter ended Q3 2025 · Filed November 14, 2025 · Accession 0001826434-25-000008
Total Value
$435.1M
Positions
18
Other Managers
0
Confidential Omitted
No
Holdings (18)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | JOHNSON & JOHNSON | JNJ | 302,831 | $56.2M | 12.91% |
| 2 | UNITED THERAPEUTICS CORP DEL | UTHR | 122,187 | $51.2M | 11.77% |
| 3 | MERCK & CO INC | MRK | 446,874 | $37.5M | 8.62% |
| 4 | AXSOME THERAPEUTICS INC | AXSM | 292,137 | $35.5M | 8.16% |
| 5 | ASCENDIS PHARMA A/S | ASND | 174,829 | $34.8M | 7.99% |
| 6 | VERA THERAPEUTICS INC | VERA | 1,190,207 | $34.6M | 7.95% |
| 7 | ARGENX SE | ARGX | 43,411 | $32.0M | 7.36% |
| 8 | MADRIGAL PHARMACEUTICALS INC | MDGL | 67,706 | $31.1M | 7.14% |
| 9 | SOLENO THERAPEUTICS INC | SLNO | 450,585 | $30.5M | 7.00% |
| 10 | ABBVIE INC | ABBV | 89,621 | $20.8M | 4.77% |
| 11 | KORRO BIO INC | KRRO | 337,764 | $16.2M | 3.72% |
| 12 | XENON PHARMACEUTICALS INC | XENE | 366,102 | $14.7M | 3.38% |
| 13 | AVADEL PHARMACEUTICALS PLC | G29687103 | 724,859 | $11.1M | 2.54% |
| 14 | STEVANATO GROUP S P A | STVN | 332,912 | $8.6M | 1.97% |
| 15 | DIANTHUS THERAPEUTICS INC | DNTH | 182,867 | $7.2M | 1.65% |
| 16 | TARSUS PHARMACEUTICALS INC | TARS | 119,260 | $7.1M | 1.63% |
| 17 | PRAXIS PRECISION MEDICINES I | PRAX | 75,986 | $4.0M | 0.93% |
| 18 | BIOHAVEN LTD | BHVN | 149,179 | $2.2M | 0.51% |